Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients

Loading...
Thumbnail Image
File version

Accepted Manuscript (AM)

Author(s)
Clark, Julia E
Graham, Nicolette
Kleidon, Tricia
Ullman, Amanda
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2019
Size
File type(s)
Location
License
Abstract

This study describes a successful, targeted intervention in central venous access device routine care to decrease central line–associated bloodstream infection. Taurolidine–citrate locks significantly reduced the rate of central line–associated bloodstream infection, particularly Gram-negative organisms without adverse events.

Journal Title

Pediatric Infectious Disease Journal

Conference Title
Book Title
Edition
Volume

38

Issue

1

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2019 Lippincott Williams & Wilkins. This is a non-final version of an article published in final form in the Pediatric Infectious Disease Journal, Volume 38 - Issue 1 - p e16–e18. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal link for access to the definitive, published version.

Item Access Status
Note
Access the data
Related item(s)
Subject

Paediatrics

Health services and systems

Public health

Science & Technology

Life Sciences & Biomedicine

Immunology

Infectious Diseases

Persistent link to this record
Citation

Clark, JE; Graham, N; Kleidon, T; Ullman, A, Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients, Pediatric Infectious Disease Journal, 2019, 38 (1), pp. E16-E18

Collections